Australia, Aug. 8 -- Incyte Holdings Corp., owns the trademark (2519645) for 'QPARIKO' till Dec. 30, 2034.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of fibrotic disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders.], 16 [Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building.] and 44 [Providing medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, fibrotic, skeletal, chondrocyte and dermatological disorders.]
Type of Mark: Word
Date of Acceptance: April 29
Registration Advertised: Aug. 7
For further details contact Frances M. Jagla Christensen O'Connor Johnson Kindness.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2519645.
Disclaimer: Curated by HT Syndication.
